Government & Foundations

The support of government agencies and charitable foundations is essential to enabling us to pursue our mission of accelerating research to improve health.

As part of efforts to support community priorities, we are actively expanding our partnerships with foundations and other funders with a focus on public health, vulnerable populations and research informatics.

Trial Innovation Network (TIN)

The Trial Innovation Network is a collaborative initiative within the CTSA Program and is composed of three key partners – the CTSA Program Hubs, the Trial Innovation Centers (TICs), and the Recruitment Innovation Center (RIC).

The vision for the Trial Innovation Network is to innovatively address critical roadblocks in clinical research and accelerate the translation of novel interventions into life-saving therapies. The Trial Innovation Network is a collaborative national network that focuses on operational innovationoperational excellence and collaboration and will leverage the expertise and resources of the CTSA Program. The Trial Innovation Network will feature a single IRB system, master contracting agreements, quality by design approaches, and a focus on evidence-based strategies to recruitment and patient engagement.

The goal of the Trial Innovation Network is to not only execute trials better, faster, and more cost-efficiently but, importantly, to be a national laboratory to study, understand and innovate the process of conducting clinical trials. UC San Francisco is a Liaison to the Recruitment Innovation Center. Learn more

National Institutes of Health

The National Institutes of Health (NIH) is part of the U.S. Department of Health and Human Services, and is the nation's medical research agency—making important discoveries that improve health and save lives. NIH is the largest source of funding for medical research in the world, and supports thousands of scientists in universities and research institutions nationwide and around the globe. It is made up of 27 Institutes and Centers, each with a specific research agenda, often focusing on particular diseases or body systems. Among these is the newly established National Center for Advancing Translational Sciences (NCATS).

As part of the NIH, the National Center for Advancing Translational Sciences (formerly known as the National Center for Research Resources) provides resources, tools, and networks to support more than 30,000 NIH-funded investigators nationwide. Among the programs administered by NCATS is the Clinical and Translational Science Awards (CTSA). Established in 2006, CTSA includes a national consortium of 60 medical research institutions in 30 states and the District of Columbia that are transforming the way biomedical research is conducted. Its goals are to speed the translation of laboratory discoveries into treatments for patients, to engage communities in clinical research efforts, and to train a new generation of clinical and translational researchers. Also see, CTSA Center for Leading Innovation and Collaboration (CLIC) website.

In 2016, we received a five-year renewal grant of $85 million to continue our work in support of clinical and translational science. Learn more

Grove Foundation

Provided a gift to launch the Master’s in Translational Medicine is a joint effort between UCSF and UC Berkeley. The two-year program was the brainchild of Andy Grove, the co-founder of Intel Corporation, who laid out his vision during a November 2009 conference at UCSF that focused on technology's role in lowering the cost of health care. Grove noted at the time that he envisioned a collaborative master's program between UCSF and UC Berkeley that would pave the way for similar efforts at other universities nationwide.

Howard Hughes Medical Institute

HHMI is a science philanthropy whose mission is to advance biomedical research and science education for the benefit of humanity. We empower exceptional scientists and students to pursue fundamental questions about living systems.